Physician profile
Beth Kepich
NPI 1538552179
$2,724.04
in general payments reported to CMS, 2019-2025
10 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,056 · 2022: $604 · 2023: $576 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $937.27 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $509.16 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $375.77 | 2021-2023 | Jardiance |
| Boston Scientific Corporation | $365.94 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $200.43 | 2021-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Scpharmaceuticals INC. | $124.74 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $111.29 | 2021 | |
| Pfizer INC. | $35.46 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.56 | 2021 | |
| Impulse Dynamics (USA) INC. | $30.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Kepich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.